Spis treści:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- H1 2026 Unaudited Interim Report of the Krka Group and Krka.pdfH1 2026 Unaudited Interim Report of the Krka Group and Krka
- Press Release.pdfPress Release
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 32 | / | 2026 | ||||||||
| Date of issue: | 2026-07-23 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| H1 2026 Unaudited Interim Report of the Krka Group and Krka, d. d. | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieżące i okresowe | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 136 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the Unaudited Interim Financial Report of the Krka Group and Krka, d. d., Novo mesto for the six months ended 30 June 2026. The report will be published on the Company's website (www.krka.biz) from 23 July 2026 onwards, for a minimum 10 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| H1 2026 Unaudited Interim Report of the Krka Group and Krka.pdf H1 2026 Unaudited Interim Report of the Krka Group and Krka.pdf | H1 2026 Unaudited Interim Report of the Krka Group and Krka | ||||||||||
| Press Release.pdf Press Release.pdf | Press Release | ||||||||||
| Legal framework | Type of information | ||||
| TRANSD | Half year financial report | ||||
| RegulatoryData | |||||
| Collection Body | PLKNF | ||||
| Unique data record identifier | |||||
| Type of submission | New (to be used for new information) | ||||
| Voluntary information flag |  | ||||
| Date or period covered [Date or beginning of the period to which the information relates] | 2026-01-01 | ||||
| Date or period covered [Date or end of the period to which the information relates] | 2026-06-30 | ||||
| Personal data flag | | ||||
| Macierzyste państwo członkowskie, w stosownych przypadkach | PL | ||||
| DocumentReference | |||||
| Język, w którym przekazano informacje | Oryginał (ORIG) czy tłumaczenie (TRAN) | Numer referencyjny pliku danych | |||
| PL | ORIG | ||||
| SubmittingEntity | |||||
| Submitting entity LEI | or | Submitting entity name - natural person | |||
| RelatedEntity/LegalPerson | |||||
| Entity LEI | Size of the entity | Industry sector(s) | |||
| 549300H9RLRTRTLRUZ73 | Large group | (acc. NACE): C | |||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2026-07-23 | Jože Colarič | President of the Management Board and CEO | |||
